Veraxa Biotech Holding AG (VRXA) Current Assets (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has reported Current Assets for 2 consecutive years, with $3.6 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Current Assets fell 43.61% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2025 stood at $3.6 million (down 43.61% YoY), and the FY2025 full-year result was $3.6 million, down 43.61% from the prior year.
• Current Assets slipped to $3.6 million in Q4 2025 per VRXA's latest filing, from $6.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $6.4 million in Q4 2024 to a low of $3.6 million in Q4 2025.